10 Best “Strong Buy” Stocks — IPXL STMP TNK and more

This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.

Shares of Impax Laboratories, Inc. (IPXL) have leaped 61% since January 1. Impax Laboratories develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. For more information, get Portfolio Grader’s complete analysis of IPXL stock.

The price of Stamps.com (STMP) has seen a 61.2% boost since the first of the year. Stamps.com is an Internet-based company that allows customers to send mail. For more information, get Portfolio Grader’s complete analysis of STMP stock.

Teekay Tankers Ltd. Class A (TNK) has risen 61.7% since the first of the year. Teekay Tankers owns oil tankers and transports crude oil. For more information, get Portfolio Grader’s complete analysis of TNK stock.

The price of Sucampo Pharmaceuticals, Inc. Class A (SCMP) has seen a 63.2% boost since the first of the year. Sucampo Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. For more information, get Portfolio Grader’s complete analysis of SCMP stock.

Since the first of the year, the price of China Biologic Products, Inc. (CBPO) has swelled 76.3%. China Biologic Products is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. For more information, get Portfolio Grader’s complete analysis of CBPO stock.

Shares of Ellie Mae, Inc. (ELLI) have leaped 79.5% since January 1. Ellie Mae provides business automation software for the mortgage industry in the United States. Trade volume rose notably over the past week, up 100.6%. For more information, get Portfolio Grader’s complete analysis of ELLI stock.

Since January 1, Ebix, Inc. (EBIX) has climbed 85.6%. Ebix provides a series of application software products for the insurance industry, including carrier systems and agency systems. For more information, get Portfolio Grader’s complete analysis of EBIX stock.

Since the first of the year, shares of ABIOMED, Inc. (ABMD) have soared 97%. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. For more information, get Portfolio Grader’s complete analysis of ABMD stock.

Since January 1, Skechers U.S.A., Inc. Class A (SKX) has jumped 114.7%. Skechers USA designs, makes, markets and distributes footwear. For more information, get Portfolio Grader’s complete analysis of SKX stock.

Shares of Chimera Investment Corporation (CIM) have risen 317.6% since January 1. Chimera Investment is a specialty finance company that invests in residential mortgage-backed securities, residential mortgage loans, real estate-related securities, and various other asset classes. The stock’s trailing PE Ratio is 5.30. For more information, get Portfolio Grader’s complete analysis of CIM stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/07/10-best-strong-buy-stocks-ipxl-stmp-tnk-and-more-ipxl-stmp-tnk/.

©2022 InvestorPlace Media, LLC